Learning Objectives:
1.Review mechanistic overlap between atherosclerosis and common rheumatologic diseases
2.Review trials of disease modifying therapies for cardiovascular disease
3.Discuss future directions for cardiovascular disease modifying therapy and rheumatologic disease
Session date:
12/19/2023 - 8:30am to 9:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Chelsea Thompson